James H. Brennan serves as Executive at COMMONWEALTH BIOTECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, James H. Brennan has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 29, 2008 involved receiving (via award) 25,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 29, 2008 | CBTE | $0 | Award | 25,000 | $N/A | Discretionary |
James H. Brennan currently holds 34,866 shares of COMMONWEALTH BIOTECHNOLOGIES INC (CBTE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James H. Brennan has been a net neutral trader of CBTE stock. They have purchased $0 and sold $0 worth of shares.
James H. Brennan's most recent insider trade was on Dec 29, 2008, when they sold 25,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted